German pharmaceutical company Bionorica put up for sale an unfinished plant in Voronezh. The fact that the German pharmaceutical company Bionorica began looking for buyers for its plant for the production of drugs in Voronezh, was told by a source close to the company that was considering the acquisition of this enterprise. According to him, the decision to sell is related to the sanctions restrictions imposed by the European Union on Russia, as a result of which the import of foreign raw materials and special equipment necessary for the production of medicines into Russia has become impossible. Nevertheless, Bionorica is still operating in Russia with a Hufe Sales team, importing pharmaceuticals from the German headquarter.